Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24043982 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hidenori Akaihata und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan. Hauptthemen laut MEDLINE: Ischemia, Receptor, PAR-2, Tryptases, Urinary Bladder. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We aimed to investigate the relationship between mast cell (MC) infiltration into the bladder with urothelial barrier dysfunction and bladder hyperactivity in a chronic bladder ischemia (CBI) rat model. We compared CBI rats (CBI group; n = 10) with normal rats (control group; n = 10). We measured the expression of mast cell tryptase (MCT) and protease-activated receptor 2 (PAR2), which are correlated with C fiber activation via MCT, and Uroplakins (UP Ia, Ib, II and III), which are critical to urothelial barrier function, via Western blotting. The effects of FSLLRY-NH2, a PAR2 antagonist, administered intravenously, on the bladder function of CBI rats were evaluated with a cystometrogram. In the CBI group, the MC number in the bladder was significantly greater (p = 0.03), and the expression of MCT (p = 0.02) and PAR2 (p = 0.02) was significantly increased compared to that of the control group. The 10 μg/kg FSLLRY-NH2 injection significantly increased the micturition interval of CBI rats (p = 0.03). The percentage of UP-II-positive cells on the urothelium with immunohistochemical staining was significantly lower in the CBI group than in the control group (p < 0.01). Chronic ischemia induces urothelial barrier dysfunction via impairing UP II, consequently inducing MC infiltration into the bladder wall and increased PAR2 expression. PAR2 activation by MCT may contribute to bladder hyperactivity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan.
- Department of Urology, Nagano Prefectural Shinshu Medical Center, 1332 Suzaka, Nagano 382-8577, Japan.
ORCID-Profile: Kanako Matsuoka, Ruriko Honda-Takinami, Seiji Hoshi
Zitieren
APA
Akaihata, H., Matsuoka, K., Hata, J., Harigane, Y., Yaginuma, K., Endo, Y., Imai, H., Matsuoka, Y., Onagi, A., Tanji, R., Honda-Takinami, R., Hoshi, S., Koguchi, T., Sato, Y., Kataoka, M., Uemura, M., Igawa, Y., & Kojima, Y. (2023). Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043982
Vancouver
Akaihata H, Matsuoka K, Hata J, Harigane Y, Yaginuma K, Endo Y, et al. Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043982
BibTeX
@article{Akaihata2023,
author = {Akaihata, Hidenori and Matsuoka, Kanako and Hata, Junya and Harigane, Yuki and Yaginuma, Kei and Endo, Yu and Imai, Hitomi and Matsuoka, Yuta and Onagi, Akifumi and Tanji, Ryo and Honda-Takinami, Ruriko and Hoshi, Seiji and Koguchi, Tomoyuki and Sato, Yuichi and Kataoka, Masao and Uemura, Motohide and Igawa, Yasuhiko and Kojima, Yoshiyuki},
title = {Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24043982}
}
EUVIMED